Skip to main content
. 2023 Sep 27;15(9):e46091. doi: 10.7759/cureus.46091

Table 2. Patient demographics and baseline characteristics.

 

Author Name Julio Rosenstock 2021 [19] Dominik Dahl 2022 [23] Juan Pablo Frias 2021 [24] Bernhard Ludvik 2021 [25] Juan Pablo Frias 2020 [26] Juan Pablo Frias 2018 [27]
Tirzepatide Placebo Tirzepatide Placebo Tirzepatide Semaglutide Tirzepatide Degludec Tirzepatide Placebo Tirzepatide Placebo Dulaglutide
No. of patient 5mg: 121 10mg: 121 15mg: 121 115 5mg: 116 10mg: 119 15mg: 120 120 5mg: 470 10mg: 469 15mg: 470 469 5mg: 358 10mg: 360 15mg: 359 360 15mg: 28 26 5mg:55 10mg:51 15mg:53 51 54
Gender (Male) 5mg: 56 10mg: 72 15mg: 63 56 5mg: 61 10mg: 72 15mg: 65 66 5mg: 205 10mg: 238 15mg: 214 225 5mg: 200 10mg: 195 15mg: 194 213 15mg: 16 12 5mg:34 10mg:30 15mg:22 29 24
Gender (Female) 5mg: 65 10mg: 49 15mg: 58 59 5mg: 55 10mg: 47 15mg: 55 54 5mg: 265 10mg: 231 15mg: 256 244 5mg: 158 10mg: 165 15mg: 165 147 15mg:12 14 5mg:21 10mg:21 15mg:31 22 30
Mean Age 5mg: 54 10mg:56 15mg: 53 54 5mg: 62 10mg: 60 15mg: 61 60 5mg: 56 10mg: 57 15mg: 56 57 5mg: 57 10mg: 57 15mg: 57 58 15mg: 55 56 5mg:58 10mg:56 15mg:56 56 58
Baseline HbA1C 5mg:7.97 10mg:7.90 15mg: 7.85 8.05 5mg: 8.3 10mg: 8.4 15mg: 8.2 8.37 5mg: 8.32 10mg: 8.3 15mg: 8.3 8.25 5mg:  8.17 10mg: 8.18 15mg: 8.21 8.12 15mg: 8.5 8.2 5mg:8.2 10mg: 8.2 15mg: 8.1 8 8.1
Baseline BMI 5mg:32.2 10mg:32.2 15mg:31.5 31.7 5mg: 34 10mg: 33 15mg: 33 33.2 5mg: 33.8 10mg:34.3 15mg:34.5 34.2 5mg:33.6 10mg:33.4 15mg:33.7 33.4 15mg: 32 32.5 5mg:33 10mg:32 15mg: 32 32 32
Duration of Diabetes (years) 5mg: 4.6 10mg: 4.9 15mg: 4.8 4.5 5mg: 14 10mg: 13 15mg: 14 12.9 5mg:9.1 10mg:8.4 15mg:8.7   8.3 5mg:8.5 10mg:8.4 15mg: 8.5 8.1 15mg: 8.2 8.8 5mg: 8.9 10mg:7.9 15mg: 8.5 8.6 9.3